We found that CRC patients have significantly higher levels of CD33+ cells than both PBC and HD (CRC: 85.28 ± 1.98% versus PBC: 73.03 ± 2.73% and HD: 77.96 ± 2.85%, Figure 1(a)). Here, CD33 is linked to colorectal carcinoma.